Physician profile
John C Elfar
NPI 1831108570
$2,681.44
in general payments reported to CMS, 2019-2025
10 companies · $699 in 2025
The $699 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.02 · 2020: $375 · 2021: $1,000 · 2023: $250 · 2024: $270 · 2025: $699.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,219.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $1,375.00 | 2020-2021 | |
| Smith+Nephew, INC. | $590.17 | 2023-2025 | Real Intelligence, "Acticoat 4"" X 4""", Pico 14 |
| Stryker Corporation | $157.31 | 2025 | Mako |
| Integra Lifesciences Corporation | $143.95 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medtronic, INC. | $127.22 | 2024 | Mazor X System |
| Arthrex, INC. | $113.69 | 2019-2023 | Arthrex |
| Impactortho, INC. | $76.70 | 2024-2025 | |
| Novus Surgical Solutions LLC | $57.02 | 2019 | |
| Lifenet Health | $24.15 | 2025 | Graftlink |
| Flower Orthopedics Coporation | $16.23 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Elfar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.